GANX GAIN THERAPEUTICS INC Delisting Actions 8-K Filing 2024 - Nasdaq Compliance Gain Therapeutics, Inc. has regained compliance with Nasdaq's minimum market value requirement of $50 million, closing the matter after previously being notified of non-compliance.Get access to all SEC 8-K filings of the GAIN THERAPEUTICS INC